National Institute for Clinical Excellence (NICE): Is Economic Appraisal Working?
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 95, doi. 10.2165/00019053-200220003-00010
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2002 AND VI 20 AND IP 15
Results: 15
1
2
Concluding Remarks.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 107, doi. 10.2165/00019053-200220003-00011
- By:
- Publication type:
- Article
3
The Value of Improving the Productivity of the Drug Development Process: Faster Times and Better Decisions.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 1, doi. 10.2165/00019053-200220003-00001
- By:
- Publication type:
- Article
4
Returns on Research and Development for 1990s New Drug Introductions.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 11, doi. 10.2165/00019053-200220003-00002
- By:
- Publication type:
- Article
5
A Profile of the Health Sector in the United States.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 31, doi. 10.2165/00019053-200220003-00003
- By:
- Publication type:
- Article
6
Meeting the Challenges to European Healthcare: Lessons Learned from the ‘Stockholm Revolution’.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 47, doi. 10.2165/00019053-200220003-00004
- By:
- Publication type:
- Article
7
The Prospects for Reform of the Japanese Healthcare System.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 55, doi. 10.2165/00019053-200220003-00005
- By:
- Publication type:
- Article
8
Balancing the Cost and Value of Medications: The Dilemma Facing Clinicians.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 67, doi. 10.2165/00019053-200220003-00006
- By:
- Publication type:
- Article
9
The Ågrenska Centre: A Socioeconomic Case Study of Rare Diseases.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 73
- By:
- Publication type:
- Article
10
The Role of Marketing in Pharmaceutical Research and Development.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 77, doi. 10.2165/00019053-200220003-00008
- By:
- Publication type:
- Article
11
Reimbursement and Cost Containment: A German Perspective.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 87, doi. 10.2165/00019053-200220003-00009
- By:
- Publication type:
- Article
12
Health state preference assessment in diabetic peripheral neuropathy.
- Published in:
- 2002
- By:
- Publication type:
- journal article
13
Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
- Published in:
- 2002
- By:
- Publication type:
- journal article
14
Quality of life in patients with epilepsy and impact of treatments.
- Published in:
- 2002
- By:
- Publication type:
- journal article
15
Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?
- Published in:
- 2002
- By:
- Publication type:
- journal article